Authors


Whitney J. Palmer

Latest:

Those With HIV Shown to Have More Coronary Plaque

Even if HIV-positive individuals have a low-to-moderate risk for cardiovascular disease, they still experience more coronary plaque.



Syra Madad, DHSC, MSC; and Vikram Mukherjee, MD

Latest:

10 Key Pillars to an Effective Ebola Response

EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.


Kristin L. Feick, PHARMD, BCPS

Latest:

Oral Therapeutic Options to Prevent Disease Progression From COVID-19 in an Ambulatory Setting

As the number of COVID-19 cases continues to rise, oral treatment options for at-home use are in demand to provide early intervention and reduce the progression to severe disease, hospitalization, and death.


Michael Trisler, PharmD, MPH, BCIDP

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.



Lynn Wardlow, PharmD, MBA, MS, BCIDP, AAHIVP

Latest:

Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) Bacteremia

Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).


Cynthia Miller, MD, MPH

Latest:

The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple Aim

Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.



Olivia G. Funk, PharmD

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Dhruv P. Patel, MD

Latest:

Revisiting Old Foes: Updates on HSV

Herpes simplex viruses are chronic infections that underscore racial and ethnic disparities and are afflicting adolescents in increasing numbers.


Yosef Nissim PharmD, BCIDP

Latest:

CDC Updates Pneumococcal Conjugate Vaccine Recommendations

The federal agency recommends using either PCV13 or PCV15 as part of a 4-dose series for pediatric patients between the ages of 2-59 months.


Karisma Patel, PharmD, BCPPS, BCIDP

Latest:

Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.


Megan Chatowsky, PharmD Candidate

Latest:

Secnidazole Offers Hope as Option for Treating Trichomoniasis in Women

This nitroimidazole antibiotic is shown to be efficacious for this condition.


Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP

Latest:

Antibiotic Stewardship in Outpatient Care

Although there are challenges for clinical and infectious disease pharmacists when trying to apply this concept, here are some considerations and strategies to employ stewardship in this setting.


Ian Cook, PharmD, BCACP, AAHIVP, DPLA

Latest:

340B Drug Pricing Program: What Is It and Why Is It Important?

The 340B program has had a great impact on access to HIV treatment and prevention services in the US.


Joseph Glowacki, DO

Latest:

Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.


Jason M. Broderick

Latest:

MRNA COVID-19 Vaccines and Male Fertility

According to a small study, the Moderna and Pfizer COVID-19 vaccines do not impact male fertility.


Grace McComsey, MD, FIDSA

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.



Geraldine A. Finlay, MD

Latest:

Identifying Disparities in Sepsis Diagnosis for Unbiased Care

Risk of inaccuracy with pulse oximeters and clinician knowledge gaps in people of color may affect sepsis evaluations and impact treatment plans.



George Loukatos, MD

Latest:

Future Directions for Managing COVID-19 and Influenza

George Loukatos, MD, shares clinical pearls for the management of the SARS-CoV-2 and influenza viruses.


Subramanya Shyam Ganti, MD, MBBS

Latest:

Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.



Jennifer Cocohoba, PharmD

Latest:

Contemporary Issues on the Treatment of Women Living with HIV in the US

The increasing presence of multiple non-AIDS comorbidities in women and others living with HIV challenges clinicians to steer away from the approach of optimizing individual chronic conditions but to think more holistically.


Paul Monach, MD, PhD

Latest:

From Pandemic to Endemic

A research agenda focusing on breakthrough infections, reinfections, severity, and sequelae is needed to inform clinical practice when COVID-19 emphasis shifts from eradication to living with the disease.


Karrine D. Brade, PHARMD, BCPS AQ-ID, BCIDP

Latest:

So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.


Mary Joyce B. Wingler PHARMD, BCIDP

Latest:

The ART of Implementing an Antiretroviral Stewardship Program

By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.

© 2024 MJH Life Sciences

All rights reserved.